Phase 2b Study of EVO756 in Adults With Atopic Dermatitis

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(25 sites)

United States

Center for Dermatology Clinical Research, Fremont, California

Metropolis Dermatology - Downtown Los Angeles, Los Angeles, California

Skin and Beauty Center, Pasadena, California

Skin Care Research, LLC, Boca Raton, Florida

Driven Research, LLC, Coral Gables, Florida

Skin Care Research - Hollywood Dermatology, Hollywood, Florida

TrueBlue Clinical Research, Tampa, Florida

DS Research, Clarksville, Indiana

Equity Medical, Bowling Green, Kentucky

Aesthetic and Dermatology Center, Rockville, Maryland

Great Lakes Research Group, Inc., Bay City, Michigan

Revival Research Institute, LLC, Troy, Michigan

Empire Dermatology, East Syracuse, New York

Equity Medical, New York, New York

Skin Search of Rochester, Inc., Rochester, New York

Wilmington Dermatology Center, Wilmington, North Carolina

International Clinical Research - Murfreesboro, Murfreesboro, Tennessee

Stryde Research, Lewisville, Texas

Progressive Clinical Research, San Antonio, Texas

Jordan Valley Dermatology Center, South Jordan, Utah

New Zealand

Pacific Clinical Research Network (PCRN) - Christchurch, Christchurch Central City, Christchurch

Optimal Clinical Trials, Auckland, NZL

Clinical Trials NZ Limited, Hamilton, NZL

Momentum Clinical Research Lower Hutt, Lower Hutt, NZL